Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

EMBC - Embecta Corp.


IEX Last Trade
20.515
0.235   1.146%

Share volume: 0
Last Updated: Thu 26 Dec 2024 03:30:04 PM CET

PREVIOUS CLOSE
CHG
CHG%

$20.28
0.24
1.16%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Company vs Stock growth
vs
Performance
5 Days
0.25%
1 Month
40.74%
3 Months
39.67%
6 Months
66.09%
1 Year
10.34%
2 Year
-26.31%
Key data
Stock price
$20.52
P/E Ratio 
13.53
DAY RANGE
N/A - N/A
EPS 
$1.20
52 WEEK RANGE
$10.33 - $21.48
52 WEEK CHANGE
$7.47
MARKET CAP 
942.848 M
YIELD 
3.56%
SHARES OUTSTANDING 
57.702 M
DIVIDEND
$0.15
EX-DIVIDEND DATE
08/27/2024
NEXT EARNINGS DATE
11/19/2024
BETA 
1.47
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$521,566
AVERAGE 30 VOLUME 
$551,187
Company detail
CEO: Devdatt Kurdikar
Region: US
Website: embecta.com
Employees: 1,900
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Embecta Corp. focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications. The company primarily sells its products to wholesalers and distributors in the United States and internationally.

Recent news